Cashman Neil 4
4 · ProMIS Neurosciences Inc. · Filed Sep 24, 2025
Insider Transaction Report
Form 4
Cashman Neil
DirectorChief Scientific Officer
Transactions
- Award
Option (right to buy)
2025-09-22+165,000→ 165,000 totalExercise: $0.45Exp: 2035-09-22→ Common Shares (165,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest on September 1, 2026, and the balance shall vest ratably over 36 months